BLACK WEEKSBočice −15% · kompleti −10% · ostalo −5%s kodomBesplatna dostava u Njemačkoj od 200 €

Ova je stranica automatski prevedena i može sadržavati pogreške. Jeste li izvorni govornik? Rado ćemo primiti vaše povratne informacije i ispravke.Pošaljite povratne informacije

The Peptide Desk The Peptide Desk
BPC-157 Oral, fotografija proizvoda
Healing Oral

BPC-157 Oral

Healing Oral

  • Šalje se iz Njemačke

Narudžba

Jedinična cijena - Besplatna dostava u Njemačkoj iznad 200 € tijekom akcije Black Weeks
  • DHL s praćenjem
  • Diskretno pakiranje

4.6 od 5 na Trustpilotu73 recenzija

Na prvi pogled

BPC-157 Oral u brojkama

Ključni podaci iz našeg leksikona.

Cijeli članak u leksikonu
Class
Pentadecapeptidehealing, oral
Use
Oralcapsule, 500mcg
Sizes
500 mcg1 size in the shop

What studies show

The source in the lexicon
  1. Stable gastric pentadecapeptide BPC 157 and wound healing (review) (opens in a new tab)

    Seiwerth, Sikiric et al., Frontiers in Pharmacology, 2021

Za BPC-157 Oral još nema laboratorijske analize. Glasaj za toDajte sami na testiranje, mi plaćamo polaSve laboratorijske analize

Znanje

Sve o BPC-157 Oral

FAQ

Česta pitanja

Izvori za svaki odgovor: članak u leksikonu

Imate još pitanja?

Pišite nam, naš tim će vam pomoći.

Is the capsule different from the tablet?

Not in terms of the compound. Capsule and tablet both contain BPC-157, only the shell differs. There are no comparative data on capsule versus tablet and no human study of either form.

Is BPC-157 absorbed by mouth at all?

According to a review by the developer group, BPC-157 is stable in human gastric juice. In rat studies it worked via the drinking water much like when injected. There are no blood measurements after oral dosing. After dosing into muscle 14 to 19 percent reached the blood in rats and 45 to 51 percent in dogs, the half-life was under 30 minutes.

What do the animal studies show for the gut?

In rats with a fistula between colon and skin the colon and skin defects healed faster when BPC-157 was injected or added to the drinking water. In short bowel syndrome the animals given BPC-157 by mouth or by injection started gaining weight again right away. There are also findings on alcohol and painkiller damage to the stomach and oesophagus.

Are there studies in humans?

Very few. A systematic review up to June 2026 found three studies with 30 people in total: knee injections, dosing into the bladder and a small safety study into a vein. All without a control group, none with a capsule or tablet. A registered phase 1 tablet trial from 2015 has not published results to this day.

Which trials are running right now?

As of 26 October 2026 no trial with BPC-157 is recruiting. A phase 1 trial with 30 planned participants after shoulder surgery has been announced, where BPC-157 is injected under the skin, with the start planned for January 2027. No capsule trial is registered.

Which side effects are known?

No treatment-related side effects occurred in the three small human studies, but the certainty is very low. One review found no clinical safety data and names risks from unregulated manufacturing and contamination. There are no data of its own on the capsule.

Povezano

Srodni proizvodi